| Product NDC: | 11822-0374 |
| Proprietary Name: | migraine relief |
| Non Proprietary Name: | Acetaminophen, Aspirin, Caffeine |
| Active Ingredient(s): | 250; 250; 65 mg/1; mg/1; mg/1 & nbsp; Acetaminophen, Aspirin, Caffeine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 11822-0374 |
| Labeler Name: | Rite Aid Corporation |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA075794 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020514 |
| Package NDC: | 11822-0374-3 |
| Package Description: | 250 TABLET in 1 BOTTLE (11822-0374-3) |
| NDC Code | 11822-0374-3 |
| Proprietary Name | migraine relief |
| Package Description | 250 TABLET in 1 BOTTLE (11822-0374-3) |
| Product NDC | 11822-0374 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Acetaminophen, Aspirin, Caffeine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020514 |
| Marketing Category Name | ANDA |
| Labeler Name | Rite Aid Corporation |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Strength Number | 250; 250; 65 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |